Shin Nippon Biomedical Laboratories, Ltd.
TSE:2395.T
1,227 (JPY) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Shin Nippon Biomedical Laboratories, Ltd. |
Symbool | 2395.T |
Munteenheid | JPY |
Prijs | 1,227 |
Beurswaarde | 51,082,379,337 |
Dividendpercentage | 3.53% |
52-weken bereik | 970 - 1,996 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D. |
Website | https://www.snbl.co.jp |
An error occurred while fetching data.
Over Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)